Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.
about
Small-molecular modulators of cancer-associated epigenetic mechanisms.Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism.An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments.Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.Epigenetics: A primer for clinicians.TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy.Synthesis, LSD1 Inhibitory Activity, and LSD1 Binding Model of Optically Pure Lysine-PCPA Conjugates.Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architecturesThe KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.Histone Lysine Demethylase Inhibitors.Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.C-H activation enables a rapid structure-activity relationship study of arylcyclopropyl amines for potent and selective LSD1 inhibitors.Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
P2860
Q34628002-0F3770CF-995A-4B22-BE78-7C5F70A2FFC3Q34793685-8DC98867-50D1-4627-9241-FF13521652EBQ38034731-0E40CA2D-AFFE-4DBF-A007-0D54744DC57DQ38132808-C50207D1-DD91-445E-BB12-89B3701D0C42Q38233723-59E55FFE-DE00-4EFF-AE93-C55E43C806E6Q38728613-5993D8BF-57BA-4948-B034-24649F4E7D3DQ38770916-DA5E563D-8263-4412-95A8-B9F5A0D41ACDQ38814417-F623E3B2-636A-4E4C-9BEC-8D2AEFF05CC5Q38887327-D3D03452-766F-4B7F-93A9-6E7330762A3CQ38905191-BA5AF512-05B3-4BE7-8F68-EEDC6F580EC5Q39061338-DA6BBD24-3930-4B81-872A-FA6404ACB97AQ39066287-03589A73-4709-4493-999A-77B6032D05D3Q39171023-0F163822-8E74-4401-A505-C6A922F4B1C1Q42399366-8BA5A1DE-5719-4227-894D-F80507B86B4AQ48533330-D5C72FF3-F3A8-4E3C-AAE3-D6BD2CE3A05FQ52853055-291180CA-38E8-49BC-9BFE-CA15F50A71C1Q53234088-2913723B-6C4A-4004-A9D9-1C7BCC4B24A8
P2860
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@en
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@nl
type
label
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@en
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@nl
prefLabel
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@en
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@nl
P2093
P1476
Synthesis and biological activ ...... thylase 1 selective inhibitor.
@en
P2093
Daisuke Ogasawara
Hidehiko Nakagawa
Koichi Koseki
Koshiki Mino
Makoto Hasegawa
Mohammed Naseer Ahmed Khan
Naoki Miyata
Ryuzo Sasaki
Takayoshi Suzuki
P304
P356
10.1016/J.BMC.2010.12.024
P407
P577
2010-12-22T00:00:00Z